1. Home
  2. MDWD vs GPRO Comparison

MDWD vs GPRO Comparison

Compare MDWD & GPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • GPRO
  • Stock Information
  • Founded
  • MDWD 2000
  • GPRO 2004
  • Country
  • MDWD Israel
  • GPRO United States
  • Employees
  • MDWD N/A
  • GPRO N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • GPRO Industrial Machinery/Components
  • Sector
  • MDWD Health Care
  • GPRO Consumer Discretionary
  • Exchange
  • MDWD Nasdaq
  • GPRO Nasdaq
  • Market Cap
  • MDWD 208.2M
  • GPRO 118.4M
  • IPO Year
  • MDWD 2014
  • GPRO 2014
  • Fundamental
  • Price
  • MDWD $20.72
  • GPRO $0.78
  • Analyst Decision
  • MDWD Strong Buy
  • GPRO Hold
  • Analyst Count
  • MDWD 2
  • GPRO 1
  • Target Price
  • MDWD $35.00
  • GPRO $1.50
  • AVG Volume (30 Days)
  • MDWD 49.2K
  • GPRO 4.0M
  • Earning Date
  • MDWD 08-13-2025
  • GPRO 08-05-2025
  • Dividend Yield
  • MDWD N/A
  • GPRO N/A
  • EPS Growth
  • MDWD N/A
  • GPRO N/A
  • EPS
  • MDWD N/A
  • GPRO N/A
  • Revenue
  • MDWD $19,213,000.00
  • GPRO $780,312,000.00
  • Revenue This Year
  • MDWD $20.80
  • GPRO N/A
  • Revenue Next Year
  • MDWD $26.92
  • GPRO $6.79
  • P/E Ratio
  • MDWD N/A
  • GPRO N/A
  • Revenue Growth
  • MDWD N/A
  • GPRO N/A
  • 52 Week Low
  • MDWD $14.14
  • GPRO $0.40
  • 52 Week High
  • MDWD $22.51
  • GPRO $1.76
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 64.88
  • GPRO 52.26
  • Support Level
  • MDWD $19.07
  • GPRO $0.72
  • Resistance Level
  • MDWD $19.55
  • GPRO $0.81
  • Average True Range (ATR)
  • MDWD 0.65
  • GPRO 0.05
  • MACD
  • MDWD 0.12
  • GPRO -0.01
  • Stochastic Oscillator
  • MDWD 94.01
  • GPRO 41.06

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About GPRO GoPro Inc.

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.

Share on Social Networks: